通用名称

glecaprevir/pibrentasvir

儿科标签批准日期

2019/9/26 0:00:00

特定指示/秒

Chronic hepatitis C virus infection (HCV) 12 years and older or weighing at least 45 kg

标签更改摘要

- The treatment duration for chronic HCV for treatment-naïve patients was changed from 12 weeks to 8 weeks. - The new 8-week treatment duration for genotypes (GTs) 1,2,3,4,5 and 6 for treatment-naïve patients with compensated cirrhosis with Chronic Hepatitis C Virus (HCV) infection is supported by the EXPEDITION-8 study. - Information on dosing, and clinical trial. - New dosing regimen. - Postmarketing study.

治疗类别

Antivirals

立法类型

PREA Only

产品说明书链接